CORC

在结果中检索

CORC

浏览/检索结果: 共17条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:  Li, Xinghui;  Shen, Jinwen;  Xia, Fan;  Zhu, Ji
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载：44/0  |  提交时间：2022/02/14
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer A Randomized Clinical Trial 期刊论文
JAMA NETWORK OPEN, 2021, 卷号: 4
作者:  Li, Ning;  Zhu, Yuan;  Liu, Lu-Ying;  Feng, Yan-Ru;  Wang, Wen-Ling
收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma 期刊论文
CANCER RADIOTHERAPIE, 2021, 卷号: 25
作者:  Zeng, J.;  Cui, X.;  Cheng, L.;  Chen, Y.;  Du, X.
收藏  |  浏览/下载：21/0  |  提交时间：2021/08/31
Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Ding, Xiaowen;  Mo, Wenju;  Xie, Xiaohong;  Wang, Ouchen;  Ding, Yuqin
收藏  |  浏览/下载：16/0  |  提交时间：2022/01/10
Atezolizumab in combination with bevacizumab in patients with unresectable locally advanced or metastatic mucosal melanoma: Interim analysis of an open-label phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Si, Lu;  Fang, Meiyu;  Chen, Yu;  Mao, Lili;  Zhang, Peng
收藏  |  浏览/下载：18/0  |  提交时间：2022/01/10
Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong
收藏  |  浏览/下载：18/0  |  提交时间：2022/01/25

©版权所有 ©2017 CSpace - Powered by CSpace